Free Fatty Acids Induce a Proinflammatory Response in Islets via the Abundantly Expressed Interleukin-1 Receptor I
- 9 October 2009
- journal article
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (12), 5218-5229
- https://doi.org/10.1210/en.2009-0543
Abstract
Islets of patients with type 2 diabetes mellitus (T2DM) display features of an inflammatory process including elevated levels of the cytokine IL-1β, various chemokines, and macrophages. IL-1β is a master regulator of inflammation, and IL-1 receptor type I (IL-1RI) blockage improves glycemia and insulin secretion in humans with T2DM and in high-fat-fed mice pointing to a pivotal role of IL-1RI activity in intra-islet inflammation. Given the association of dyslipidemia and T2DM, we tested whether free fatty acids (FFA) promote the expression of proinflammatory factors in human and mouse islets and investigated a role for the IL-1RI in this response. A comparison of 22 mouse tissues revealed the highest IL-1RI expression levels in islets and MIN6 β-cells. FFA induced IL-1β, IL-6, and IL-8 in human islets and IL-1β and KC in mouse islets. Elevated glucose concentrations enhanced FFA-induced proinflammatory factors in human islets. Blocking the IL-1RI with the IL-1R antagonist (IL-1Ra) strongly inhibited FFA-mediated expression of proinflammatory factors in human and mouse islets. Antibody inhibition of IL-1β revealed that FFA stimulated IL-1RI activity via the induction of the receptor ligand. FFA-induced IL-1β and KC expression in mouse islets was completely dependent on the IL-1R/Toll-like receptor (TLR) docking protein Myd88 and partly dependent on TLR2 and -4. Activation of TLR2 in purified human β-cells and islets stimulated the expression of proinflammatory factors, and IL-1RI activity increased the TLR2 response in human islets. We conclude that FFA and TLR stimulation induce proinflammatory factors in islets and that IL-1RI engagement results in signal amplification.Keywords
This publication has 58 references indexed in Scilit:
- IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK ratProceedings of the National Academy of Sciences of the United States of America, 2009
- Immunological and Inflammatory Functions of the Interleukin-1 FamilyAnnual Review of Immunology, 2009
- Increased Interleukin (IL)-1β Messenger Ribonucleic Acid Expression in β-Cells of Individuals with Type 2 Diabetes and Regulation of IL-1β in Human Islets by Glucose and AutostimulationJournal of Clinical Endocrinology & Metabolism, 2008
- Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesityCytokine, 2008
- Using Ribosomal Protein Genes as Reference: A Tale of CautionPLOS ONE, 2008
- The Antiinflammatory Cytokine Interleukin-1 Receptor Antagonist Protects from High-Fat Diet-Induced HyperglycemiaEndocrinology, 2008
- Proliferation of sorted human and rat beta cellsDiabetologia, 2007
- The Fas pathway is involved in pancreatic β cell secretory functionProceedings of the National Academy of Sciences of the United States of America, 2007
- TLR4 links innate immunity and fatty acid–induced insulin resistanceJCI Insight, 2006
- Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytesBiochemical and Biophysical Research Communications, 2006